Cullinan Oncology Forms Strategic Collaboration Agreement with Mount Sinai to Advance Oral HPK1 Protein Degrader for Cancer Treatment

Press/Media

Period10 Jan 2022

Media coverage

1

Media coverage

  • TitleCullinan Oncology Forms Strategic Collaboration Agreement with Mount Sinai to Advance Oral HPK1 Protein Degrader for Cancer Treatment
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date10/01/22
    PersonsJian Jin